51 F
New York
Tuesday, April 20, 2021

Why Interpace Biosciences [NASDAQ: IDXG] Skyrocketing Today?

Must read

IAA [NYSE: IAA] Announces Expansion of Delivery Services in the UK

IAA, Inc. disclosed that its UK-based business unit has decided to expand its vehicle delivery services for its buyers. This expansion decision has...

ICON [NASDAQ: ICLR] Secures Multiple Categories in 2021 CRO Leadership Awards

ICON Public Limited Company has disclosed that it has won multiple categories in the annual CRO Leadership Awards. This is another greatest achievement...

Equinox Announces Sale of Pilar Gold Mine

Equinox Gold Corp. revealed Monday that it has decided to sell its Pilar Gold Mine in Brazil to Pilar Gold Inc. The firm...

OpGen [NASDAQ: OPGN] Announces Strategic Collaboration New York State Department of Health

OpGen, Inc. revealed that it has entered into a strategic collaboration deal with the New York State Department of Health. The focus of...

Interpace Biosciences, Inc. [NASDAQ: IDXG] disclosed Wednesday that the Audit Committee of the Board of Directors has reported the results of an independent investigation regarding complaints of certain employment and billing and compliance.

The Audit Committee has concluded that the accusation made in the complaints is unproven. They announced that they have found no evidence of any illegal acts.

Shares of Interpace Biosciences traded up 37.58% as it gained +1.12 during the trading session of Wednesday. It has a closing price of $4.10. IDXG has a 52-weeks low range of $2.57 and a 52-weeks high range of $11.00.

It has moved up 59.40% from its 52-weeks low and moved down -62.73% from its 52-weeks. IDXG had a trading volume of 11.36 million as compared to the average volume of 307.06K.

Looking at its liquidity, it has a current ratio of 1.80. This company market capitalization has remained high, hitting $11.95 million at the time of writing.

As for the quarter ending June 30, 2020, the company announced its failure to file its Form 10-Q in a timely manner, & the company’s notification of late filing on Form 12B-25.

Interpace Biosciences has received letters from employees, regarding employment, billing, and compliance issues. In response to this IDXG has alerted its audit committee and Regulatory Compliance Committee as well as its independent registered public accounting firm.

More articles

Latest article

Why Mer Telemanagement [NASDAQ: MTSL] Skyrocketed on Friday?

Shares of Mer Telemanagement Solutions Ltd skyrocketed during the trading session of Friday. The strong performance of the firm has indicated the positive...

Largo Resources Gets Approval for Listing on Nasdaq Stock Exchange

Largo Resources disclosed that it has finally obtained authorization from Nasdaq Stock Market LLC. As per the approval, the firm will now eligible to...

Aurora Mobile [NASDAQ: JG] Inks Agreement with Wanda Film

Aurora Mobile Limited disclosed Thursday that it has inked an agreement with Wanda Film Holding Co Ltd. Since its inception, Aurora Mobile has...

Brady [NYSE: BRC] Commence Tender Offer to Buy Nordic ID Oyj

Brady Corporation has inked an agreement with Nordic ID for its acquisition. The firm has commenced the tender offering to buy all the...

Cinedigm [NASDAQ: CIDM] Achieve Record Subscription and Ad-Supported User Growth Milestones

Shares of Cinedigm Corp. skyrocketed 19.30% after the firm reported the update about the subscription. The firm has achieved the best ever achievement...

Aurora Mobile [NASDAQ: JG] Signs Partnership Agreement with Yivi

Aurora Mobile Limited revealed that it has inked a collaboration deal with Hangzhou Yivi Intelligent Technology Co., LTD. (Yivi). Yivi and Aurora both...

Total [NYSE: TOT] Join Forces with Siemens Energy to Reduce LNG Related Emissions

Total SE has joined forces with Siemens Energy to explore the solution for the reduction of CO2 emissions. The firms have inked a...

Kaixin [NASDAQ: KXIN] Signs Cooperation Agreement with Jingdong

Kaixin Auto Holdings declared Monday that it has inked a deal with Jingdong Century Trade Limited. The agreement is the collaboration agreement between...